Comparison of usefulness of computer assisted continuous 48-h 3-lead with 12-lead ECG ischaemia monitoring for detection and quantitation of ischaemia in patients with unstable angina by Es, G.A. (Gerrit Anne) van et al.
European Heart Journal (1997) 18, 931-940
Comparison of usefulness of computer assisted
continuous 48-h 3-lead with 12-lead ECG ischaemia
monitoring for detection and quantitation of
ischaemia in patients with unstable angina
P. Klootwijk*, S. Meij*, G. A. v. Esf, E. J. Mullen}:, V. A. W. M. Umans§,
T. Lenderinkf and M. L. Simoons*
* Division of Cardiology, Thoraxcenter, University Hospital Dijkzigt, Erasmus University Rotterdam,
The Netherlands; f Data processing center Cardialysis B. V., Rotterdam, The Netherlands; ^Division of Cardiology,
Spaarne Ziekenhuis, Heemstede, The Netherlands; ^ Division of Cardiology, Medisch Centrum Alkmaar,
Alkmaar, The Netherlands
Aims The selection of ECG leads used for ST monitoring
may influence detection and quantitation of ischaemia.
Methods We compared on-line continuous 48-h 12-lead
against 3-lead ST monitoring in 130 unstable angina
patients (Mortara, ELI-100). Onset and offset of ST
episodes were defined by the lead with the first > 100 uV ST
change relative to baseline and the lead with the latest
return to baseline ST level, respectively. ST episodes were
calculated for 12 leads and 3 leads (V2, V5, III) separately.
Results ST episodes were detected in 88 patients (77%) by
12-lead and in 71 patients (62%) by 3-lead ST monitoring
(P<002). The median number (25, 75%) of episodes/patient
was 1 (0, 3) for 3-lead and 2 (1, 6) for 12-lead (P<00001).
The total duration of ischaemia detected during 12-lead
far exceeded 3-lead monitoring: 123 (1, 58-2) and
1-7 (0, 23-3) min respectively (/3<00001). The probability
of recurrent ischaemia declined most during the first 24 h of
monitoring. After a period without ST changes of 1, 12, 24
and 36 h, the probabilities of recurrent ischaemia were
63, 31, 14 and 9%, respectively.
Conclusions Continuous 12-lead ST monitoring increases
detection rate and duration of ST episodes compared to
3-lead ST monitoring. The use of continuous 12-lead ECG
monitoring devices on emergency wards and coronary care
units is recommended.
(Eur Heart J 1997; 18: 931-940)
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Introduction
Patients with unstable angina may suffer from early
unfavourable cardiac events in spite of intensive medical
therapy. Prognosis is defined primarily by the recurrence
and severity of silent or symptomatic myocardial ischae-
mia and by the presence of multivessel coronary artery
disease'1"7'. The assessment of the total ischaemic burden
and the identification of patients at risk should prefer-
ably be based on continuous ECG monitoring tech-
niques. Continuous ST monitoring, whether on-line or
by Holter recording with subsequent off-line analysis,
has been limited by a restricted number of 2 or 3 ECG
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leads. Recently, new systems have been introduced for
continuous on-line analysis of 12-leads or orthogonal
vector lead ECGs, which have overcome the limitations
of these earlier technologies'8"121. However, the
additional value of 12-lead ECG analysis over 2 or 3
leads or single lead analysis in patients with unstable
angina is not reported. Comparative studies of different
lead systems have been performed to address the value
of multilead exercise electrocardiography[13~l5]. These
results, however, may not be applicable to patients with
unstable angina, since the pathophysiology of unstable
angina differs from the pathophysiology of stable angina
(plaque rupture and coronary thrombosis vs fixed
stenosis with ischaemia due to increased myocardial
oxygen consumption).
The aim of the present study was to compare
continuous 12-lead ST monitoring with more con-
ventional 3-lead ST monitoring for detection and
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quantitation of ischaemia in patients with unstable
angina, and to investigate which leads most frequently
contribute to the detection of ST episodes. A new
algorithm for detection and quantitation of ischaemic
events is presented, which takes into account all 12 ECG
leads simultaneously.
Methods
Study patients
One hundred and thirty patients, who were hospitalized
for unstable angina and who participated in a dose-
finding study of a new anti-thrombin agent, underwent
continuous 12-lead ST monitoring in 18 hospitals (see
appendix)1'6171. Patients were eligible for the study if an
episode of chest pain was accompanied by dynamic
ST and/or T wave changes indicative of myocardial
ischaemia. Patients with ECG abnormalities, such as
left bundle branch block, left ventricular hypertrophy
or artificial pacemaker device, making ST segment
interpretation unreliable, were excluded, as were
patients with a recent myocardial infarction.
Continuous ST monitoring
Continuous ECG monitoring was performed using the
ELI-100 continuously updated 12-lead ECG monitoring
system (Mortara Instruments, Milwaukee, U.S.A.),
which automatically calculates median ECG complexes
of the 12 ECG leads every 15 s. The system was pro-
grammed to store median ECG complexes every 20 s if
> 100 uV ST segment shift was present in one lead
relative to the baseline ECG of that patient, or if
> 50 uV ST shift was present in any two leads of the
12-lead ECG. If little or no ST change was present, a
baseline median ECG was stored every 20 min.
Median ECG complexes and ST trend data
were stored on a removable hard disk or floppy disk.
After completion of the recording, this disk was sent
to the Cardialysis core laboratory (Rotterdam, The
Netherlands) for subsequent editing and analysis.
Editing and analysis of recorded data
Before editing, the 12-lead ECG templates at the start of
the continuous ECG recording were compared with the
study entry 12-lead ECGs in order to verify proper lead
placement. In the case of discordance, the recording was
rejected.
All median QRST templates were manually
scanned and edited for artifacts, intermittent bundle
branch block, detection or marker errors and postural
changes. The latter was defined as a sudden change of
the frontal QRS axis and/or a sudden QRS amplitude
change from V, to V6 or vice versa. After editing, the
trends of the ST segment level measured at the
J-point+60ms were generated for each single lead of
the 12-lead ECG, except aVR.
Reference ECG
At study entry, an attempt was made to document both
a standard 12-lead ECG during chest pain and a 12-lead
ECG without chest pain. These ECGs were used to
define a reference 'non-ischaemic' (without chest pain)
median ECG complex during the continuous ECG
recording. If the median ECG complex at the start of the
recording was similar to the study entry non-ischaemic
12-lead ECG, this ECG complex was used as the refer-
ence 'non-ischaemic' continuous ECG complex. If the
first ECG complex was not similar to the study-entry
non-ischaemic 12-lead ECG, attempts were made to
identify the most comparable 'non-ischaemic' ECG
complex of the continuous ECG recording. Subse-
quently, this ECG complex was used as the reference
'non-ischaemic' ECG.
Definition of ST episodes
The onset of an ST episode was defined as a change of
ST-amplitude in one or more leads of at least ± 100 uV
from the baseline ST level, developing within a 10 min
period and persisting for at least 1 min. The end of an
episode was defined as a return of the ST level within
± 100 uV of the baseline ST level, again lasting for at
least 1 min. Episodes had to be separated from each
other by at least 1 min. If >100uV ST change was
present in more than one lead simultaneously, the epi-
sode onset was defined by the lead exhibiting the first
significant ST change. Similarly, the end of an episode
was defined by the lead exhibiting the latest return to
baseline ST level. An example of the ST trend analysis
and representative ECG recordings is presented in
Figs 1 and 2.
Automated detection of ST segment
changes >100\iV
An algorithm programmed according to the previously
described ST criteria for ischaemia was applied to each
single lead ST trend, in order to detect both the time and
ST values of onset and offset of an ST episode and its
peak ST level. In order to prevent a reversal of baseline
with a real ST episode (or false detection of an untrue
ST episode), the algorithm was programmed to skip
episodes of which the onset ST value was closer to the
initial reference ST level than the baseline ST level
during the predefined 10 min window. In such an in-
stance, the ST value was used as baseline update for the
detection of a possible next episode.
Subsequently, the digital trend analysis was con-
firmed by a second visual analysis of the real-time ECG,
thus double checking template quality and excluding
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Figure 1 Twelve-lead ST analysis in a patient with unstable angina. The
ST trends of those leads in which ST episodes occurred are displayed,
together with the heart rate trend (bottom trend curve). The black bars in
each single lead ST trend represent the time during which the algorithm
detected a > 100 uV ST change. At the bottom of the trend graphs, the
black bars indicate the total ST episode duration (ischaemia) taking into
account all leads involved.
false-positive or false-negative automated ST measure-
ments. The ECG at moments of interest, either detected
by the algorithm or by the operator, was documented on
hard copy for visual inspection (Fig. 2).
ST episodes based on 12-lead and 3-lead
ST trends
As a final summary analysis, the total number of ST
episodes was calculated based on both the combination
of either 3 leads HI, V2 and V5 or the combination of all
12 leads (except aVR).
Statistical analysis
Continuous variables are expressed as median and inter-
quartile range (25th and 75th percentiles). Unpaired
variables were compared using the Mann-Whitney test.
Wilcoxon signed rank test was used for paired variables.
Discrete variables are described with percentages and
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Figure 2 Samples of the computer-assisted 12-lead ECG recording of the patient in Fig. 1. The upper ECG row
demonstrates the 12-lead ECG (except aVR) which has been selected as the reference, 'non-ischaemic' ECG. The ECG
rows directly below demonstrate the time and ECG lead (indicated in bold) in which the ST episode occurred. In the
upper panel, ST changes are present in multiple leads, but the ST changes of V, appear dominant. Thus the onset,
maximum and ending of the episode is detected in this lead. However, in another episode shown in the lower panel,
the onset and maximum of the ST episode is detected in lead V2, but the end of this combined episode is detected
in lead V,.
were compared using the chi-square test. The number of
episodes per patient during 3-lead and 12-lead ST moni-
toring might differ in two directions, since both more
and less frequent ST episodes might be detected by 12
leads compared with 3 leads. The latter might be due to
combining of multiple short episodes in one long epi-
sode. This would result in fewer episodes but a longer
ischaemic duration. Therefore, a two-tailed P value was
calculated in all instances. A P value of <005 was
considered statistically significant. The Kaplan-Meier
method was used for the evaluation of the time to the
occurrence of a first ST episode and the possibility of a
recurrent ST episode, with censoring of data. Statistical
difference was tested with the Log rank test.
Results
ECG monitoring was initiated in 130 patients. Good
quality recordings were eventually obtained in 114
patients (88%). The median (25, 75 percentiles) total
ECG monitoring time was 53 (49, 55) h. Total analys-
able ECG monitoring time was 44 (38, 48) h. Twelve-
lead ST monitoring detected 515 ST episodes suggestive
of transient ischaemia against 311 for 3-lead ST moni-
toring, respectively (Table 1, P<00001). This resulted in
detection of ischaemia by 12-lead ST monitoring in 88
patients (77%) vs 71 patients (62%) by 3-lead ST moni-
toring (P=002). Sixty-four of the 88 patients with ST
episodes during 12-lead monitoring had more than one
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Table 1 Summary ofST analysis parameters. Comparison of computer-assisted 3-lead against 12-lead ST monitoring
in 114 patients with unstable angina
n=114 3-leadST monitoring
12-lead
ST monitoring P value
ST episodes present (pts)
> 1 ST episode present (pts)
Total number of episodes
Patients with symptomatic ST episodes
Number of episodes/pt*
Total duration (min) of ST shift/pt*
Duration of ST episode (min)**
Mean duration of episode/pt (min)**
Time to first episode (hrs)**
71 (62%)
46
311
10 (9%)
1 (0, 3)
1-7 (0,23-3)
5 (1-3, 17-7)
7-7 (1-8, 14-4)
12-7 (5-8, 28-4)
88 (77%)
64
515
10 (9%)
2 (1,6)
12-3 (1, 58-2)
7 (1-3. 20)
10-2 (2-6, 15 2)
9-9 (4-0, 21-2)
002
002
<00001
ns
<00001
<00001
<00001
0-03
<00001
*median, 25, 75 percentiles, including patients without ischaemia.
**median, 25, 75 percentiles, patients with ischaemia only.
100
12 24 36 48
Time to first episode (h)
60 72
Figure 3 Time to the occurrence of the first ST epi-
sode after the start of ST monitoring plotted against
the cumulative percentage of patients. = 12-lead;
=3-lead.
ST episode (73%), against 46 (65%) of the 71 patients
during 3-lead monitoring (/>=002).
Several other observations support the greater
sensitivity for detection of ST segment changes of 12-
lead monitoring over 3 leads. For example, the first ST
episode during monitoring was detected earlier by 12
leads (Table 1 and Fig. 3), and the duration of ischaemia
detected by 12 leads exceeded the duration in 3 leads
(Fig. 4). Furthermore, the number of leads involved per
ST episode was higher for 12-lead than for 3-lead ST
monitoring (Table 2).
For 12-lead ST monitoring, episodes with pre-
cordial lead involvement only were far more frequently
present than episodes with only standard or augmented
lead involvement (77% against 11% respectively,
P<0-0001). Simultaneous involvement of both the
standard or augmented leads and the precordial leads
was present in 60 out of 515 ST episodes (12%).
A shift of ST episodes from either the standard or
augmented leads to the precordial leads or vice versa
occurred in 20 (31%) of the 64 patients who had more
than one ST episode during 12-lead ST monitoring.
For 3-lead ST monitoring, the single lead episodes of
V2 contributed most to the detection of the onset of
ST episodes (Fig. 5, panel B, P<00001), while V2, V3
and V4 were equally sensitive in the 12-lead analysis
(Fig. 5, panel A).
Figure 6 shows a Kaplan-Meier 'survival' analy-
sis with censoring of data of the probability to remain
free of a new ST episode during the course of the
monitoring period using 12 leads. The probability of a
recurrent ST episode declined most during the first 24 h
of monitoring. There was no difference between the
probability of occurrence of a new ST episode after the
start of the ECG monitoring period or the probability of
recurrence of a second ST episode after the first, or a
third after the second episode.
Forty-five patients (39%) had at least one episode
of chest pain during ECG monitoring. However, ST
changes of > 100 uV were present during those episodes
in 10 patients only (22%), during both 3- and 12-lead
ECGs. If additional less prominent ST and T wave
changes similar to the study entry ECG were also
taken into account, ECG signs of ischaemia were
present during chest pain in 26 patients (58%). There
was no significant difference between the number of ST
episodes in patients with and without episodes of
chest pain.
Nineteen patients (17%) suffered from an in-
hospital cardiac event and/or underwent emergency
angiography within the first 7 days of admittance to
hospital. There were no cardiac deaths. Clinical events
occurred more frequently in patients with chest pain
during the monitoring period and in patients with chest
pain and concomitant ST episodes compared to those
without recurrent ischaemia (Table 3). These obser-
vations were, however, not statistically significant in this
small series of patients.
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Figure 4 Comparison of 12-lead and 3-lead ST monitor-
ing. Panel (a) demonstrates the number of episodes per
patient for both techniques, panel (b) the duration of the
ST episodes per patient. Note: Single dots may represent
more than one patient. The encircled patients in panel (a)
show more episodes during 3-lead than 12-lead ST moni-
toring. In these patients, several isolated 3-lead ST epi-
sodes appeared to be part of one, longer lasting 12-lead ST
episode, depending on the leads involved.
Discussion
Recently, computer assisted continuous 12-lead ECG
monitoring techniques have become available for real-
time ECG and ST segment monitoring in patients
with acute coronary syndromes'8'9181. These techniques
have outgrown the limitations of serial ECG recording,
which provides snapshot information only, and Holter
ST recording, which is limited by a restricted number
of leads and allows for retrospective off-line analysis
only.
In patients with an acute myocardial infarction
receiving thrombolytic therapy, computer assisted con-
tinuous ECG monitoring has proven to be of clinical
value for prediction of vessel status and identification of
high risk patients'10"121. However, so far, no systematic
studies have been conducted to evaluate the usefulness
of computer-assisted continuous 12-lead ECG monitor-
ing techniques in patients with unstable angina. To our
knowledge, this study is the first to demonstrate the
relationship between detection and quantitation of
ischaemia and ECG monitoring technology in these
patients. Twelve lead ST monitoring appeared to be
more sensitive than the more generally applied 3-lead
technology. When only three leads were used for ST
monitoring, ischaemia was detected in 62% of patients,
which is comparable to studies using Holter ST moni-
toring in patients with unstable angina'1191. With 12-lead
ST monitoring, ischaemia was detected in an additional
15% of patients. Both the number and duration of
ischaemic episodes far increased using 12-lead compared
to 3-lead ST monitoring.
The ST changes were found to disperse and shift
among different leads in time in at least 31% of patients
with more than one ST episode during the monitoring
period. This may depend on the flow balance of the
coronary system, the degree of vessel injury and the
duration and severity of ischaemia. Thus, instead of
monitoring the lead with maximal ST deviation or sum
ST deviation in patients with myocardial infarction'202'1,
full 12-lead ST monitoring should be preferred for
detection and quantitation of ischaemia in patients with
unstable angina. The major differences between ST
monitoring of unstable angina patients vs ST monitor-
ing of acute myocardial infarction patients are listed in
Table 4.
Table 2 Number of leads involved per ST episode. Comparison of computer-assisted
3-lead and 12-lead ST monitoring
Lead
selection
3 leads
12 leads
252
283
1
(81)
(55)
Number of leads involved
2
47 (15)
97 (19)
3
12 (4)
63 (12)
per
24
ST episode (%)
4 5
(5) 14 (3)
>5
34 (7)
Total number
of ST episodes
311
515
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12-lead 3-lead
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Figure 5 Number of single ST episodes per lead and detection of earliest ST episode onset if all leads involved
are taken into account. The bars represent the number of ST episodes detected in each single lead. The tinted
areas represent the number of episodes which detected the earliest episode onset. Panel (a) detection of onset of
ST episodes when using 12-lead ST monitoring; Panel (b) detection of onset of ST episodes when using leads III,
V2 and V5 only.
ST episodes were most frequently present in the
leads V2, V3 and V4. In addition, these leads also
contributed most to the detection of the onset of ST
episodes if all involved leads were taken into account.
This is in contrast to previous studies on body surface
mapping and optimal lead placement during exercise
electrocardiography in patients with coronary artery
disease'13"151. These studies demonstrated that the single
lead with the greatest sensitivity for detecting ST seg-
ment shift was between the right infraclavicular region
area and the V5 position, which is in fact a bipolar V5
lead. Our data do not support these findings and suggest
that studies on lead placement and ST shift during
exercise testing in patients with stable angina may not be
applicable to patients with unstable angina in whom
both the underlying pathophysiological mechanism and
the extent and area of ischaemia is different'22'. In
addition, our results indicate that ST episodes with only
standard lead involvement are rare. As such, it is con-
ceivable that the applied cut-off value of >100uV ST
change is not adequate for standard lead monitoring in
general practice.
Previous studies on patients with unstable angina
demonstrated that recurrent ischaemia occurs most
frequently in the first 24-48 h of admission to hospi-
tal'22'231. This is in concordance with our finding that the
majority of patients exhibited a recurrence of ischaemia
within the first 15 h of ST monitoring, with only 23% of
patients remaining free of an ST episode during the total
monitoring period (Fig. 3). In addition, Fig. 6 demon-
strates that the distribution of the occurrence of an ST
episode over time was similar for the first interval since
the start of the ST monitoring period, as well as for
the occurrence of a second episode after the first and a
third after the second. This suggests similar underlying
pathophysiological mechanisms of these episodes'231.
Apparently, plaques stabilize and become quiescent'
after a period without recurrent ischaemia of
approximately 24 h.
In agreement with Holter ST studies in patients
with unstable angina, ST changes of >100|iV during
moments of chest pain were infrequently present, occur-
ring in only 22% of the patients with chest pain during
the monitoring period'19'24'25'. This may be due to at
least three factors: (1) complaints may not always be of
ischaemic origin, (2) the time of occurrence of com-
plaints may not always have been correctly indicated by
the patient or annotated in the case record forms, (3) the
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Figure 6 Kaplan-Meier event free survival estimate. The
curves indicate the probability of remaining free of an ST
episode during the course of the monitoring period: (1)
from start of the monitoring period ( , median time
15-3 h), (2) from the end of the first ST episode until the
second ( , median time 7-4 h) and (3) from the end of
the second ST episode until the third ( . . . . , median time
9-6 h), using 12-lead ST monitoring. The curves virtually
overlap, suggesting similar pathophysiology for the differ-
ent episodes. Plaques apparently become quiescent after a
period without ischaemia of approximately 24 h.
generally accepted > 100 uV ST change criterion for
detection of ischaemia may be too insensitive to pick up
minor ischaemic ECG changes that may occur in these
unstable patients. The latter assumption is supported by
the fact that minor ST and T wave changes, similar to
the study entry ECG during pain were present during
pain in 58% of all patients who had episodes of chest
pain during the recording. This implies that not only ST
changes of >100uV but also smaller ST and T wave
changes should be taken into account as signs of ischae-
mia in these patients. Until recently, the standardization
and automated detection and quantitation of these
minor ST and T wave changes was hampered by the
limitations of earlier ECG technologies such as Hotter,
because of baseline drift and restriction of number of
leads. In contrast, the high quality ECG signals pro-
vided by computer-assisted ECG monitoring technolo-
gies have overcome these limitations and may challenge
us to develop new ischaemia standards and algorithms
for automated detection and quantitation.
Finally, in contrast to other studies using Holter
ST recording techniques'1'19', we did not demonstrate a
significant difference in the occurrence of in-hospital
cardiac events within the first week from admittance
between patients with and without ST episodes,
although trends were similar to previous studies
(Table 3). This may be due to the small number of
patients who suffered from an in-hospital clinical event.
Table 3 Correlation of in-hospital cardiac events within 7 days from admission to
hospital with the presence of chest pain andlor ST episodes during the ECG
monitoring period
During recording Number Myocardial p T C A / C A B G
of pts infarction
Any clinical No clinical
event (%) event (%)
Chest pain
No chest pain
Chest pain + ST episode(s)
Chest pain+ corr. ST episode
No chest pain,No ST episodes
12 lead, ST episodes present
12 lead, No ST episodes
3 lead, ST episodes present
3 lead, No ST episodes
45
69
37
10
18
88
26
71
43
5
7
4
0
2
9
3
7
5
7
1
7
3
0
8
0
7
1
11 (24)
8 (12)
9 (24)
3 (30)
2 (11)
16 (18)
3 (12)
13 (18)
6 (14)
34 (76)
61 (88)
28 (76)
7 (70)
16 (88)
72 (82)
23 (88)
58 (82)
37 (80)
Table 4 Differences of ST analysis in patients with acute myocardial infarction and unstable angina
Acute myocardial infarction Unstable angina
ST monitoring of single lead with greatest ST shift will suffice in
most instances
Baseline ST level is defined by the moment of ST recovery and
ST steady state
Recurrent ischaemia is reflected by ST re-elevation instead of ST
depression in most instances
Gradual T wave changes only
Multilead ST monitoring necessary, as the ischaemic area may
vary in time. Scanning of different leads for earliest onset,
highest peak and latest end of ST episodes is necessary
Baseline ST level is not defined, a reference ECG is necessary
Ischaemia may be reflected by both ST elevation, ST depression
and T wave changes, which makes automated analysis using
computer algorithms difficult
Minor ST segment and T wave changes may reflect ischaemia,
which makes accurate quantitation of ischaemia difficult
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We conclude that computer-assisted 12-lead
ECG monitoring can be used for on-line ECG ischaemia
monitoring of unstable angina patients both for clinical
purposes and for quantitation of myocardial ischaemia
in studies. The use of continuous 12-lead ST monitoring
significantly increased the detection rate of ST episodes
as compared to more conventional continuous 3-lead ST
monitoring. Furthermore 12-lead ST monitoring yields
more episodes and longer duration of ischaemia.
Whether this also relates to a better specificity for
prediction of impending clinical events could not be
established from the small subset of patients who
actually suffered an in-hospital clinical event during
this study. Computer-assisted 12-lead ECG monitoring
systems are recommended on emergency wards and
coronary care units, not only for monitoring of patients
with an acute myocardial infarction receiving thrombo-
lytic therapy, but also for monitoring of unstable angina
patients.
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